期刊文献+

单纯性尿道下裂患者Ⅱ型5α-还原酶的活性评估

Assessment of typeⅡ5 alpha-reductase activitiy in boys with isolated hypospadias
下载PDF
导出
摘要 目的测定单纯性尿道下裂患者Ⅱ型5α-还原酶的活性。方法2005年4~9月在该院就诊患者,其中单纯性尿道下裂患者22人,对照组为包皮环切患者25人。从包皮组织制备出作为Ⅱ型5α-还原酶载体的粗微粒体悬液,根据分光光度计连续测定NADPH的OD340nm值的时间变化曲线来折算该酶的活性。结果22例单纯性尿道下裂患者Ⅱ型5α-还原酶活性为(0.3014±0.0054)μmol/(L·min),25例对照组该酶活性为(0.3065±0.0032)μmol/(L·min),前者的酶活性略低于后者,两者的酶活性结果经t检验差异无显著性。结论单纯性尿道下裂患者和正常人比较,Ⅱ型5α-还原酶的活性无明显变化。此外,从包皮组织中提取Ⅱ型5α-还原酶,根据NADPH的OD值的时间变化曲线来检测该酶的活性,具有简便快捷和经济实用的特点。 [Objective] To measure the type Ⅱ 5 alpha-reductase activity in boys with isolated hypospadias. [Methods] From April 2005 to September 2005, the type Ⅱ 5 alpha-reductase activity was measured in foreskin specimens of 22 boys with isolated hypospadias and was compared to that of healthy control subjects. A spectrophotometer was used to measure the changes of the product NADPH by monitoring the variation in absorbance at 340 nm. [Results] The activity of type Ⅱ 5 alpha-reductase did not show any significant difference between tissues acquired from boys with isolated hypospadias and normal tissues obtained from the control group (0.3014±0.0054) vs. (0.3065±0.0032) μmol/L·min). Compared to the control group, the type Ⅱ 5 alpha-reductase activity was slightly lower in the patient group. [Conclusion] There is no difference of type Ⅱ 5 alpha-reductase activity in the foreskin specimens between patients with isolated hypospadias and the control group. This method of measuring type Ⅱ 5 alpha-reductase activity has the advantages of being easy to perform.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2008年第9期1245-1247,共3页 China Journal of Modern Medicine
基金 湖南省自然科学基金资助(No:05jj30056)
关键词 Ⅱ型5α-还原酶 尿道下裂 酶活性 分光光度计 type Ⅱ 5 alpha-reductase hypospadias enzyme activity spectrophotometer
  • 相关文献

参考文献11

  • 1孙祖越,郑维君,王晓麟,屠曾宏.甾体5α-还原酶活性的新测定方法[J].中华内分泌代谢杂志,1998,14(3):206-207. 被引量:6
  • 2TTTUS MA,GREGORY CW,FORD OH.Steroid 5alpha-reductaae isozymes I and Ⅱ in recurrent prostate cancer[J].Clin Cancer Res,2005,11(12):4365-4371.
  • 3CUI YG,ZHANG GY.Steroid activity,androgen level and its receptor in the target tissues of male fetuses[J].National Journal of Andrology,2001,7(4):223-225.
  • 4YAO G,ZHAO XK,LIU R.Expefience of vascularized skin nap technique in hypespadias fistulas repair[f].China Journal of Modern Medicine,2003,13(12):111-113.
  • 5MANSON JM,CARR MC.Molecular epidemiology of hypospadias:Renew of genetic and environmental risk factors[J].Birth Defects Research Part A:Clinical and Molecular Teratology,2003,67(10):825-836.
  • 6MORENO-GARCIA M,MIRANDA EB.Chromosomal Bnomalles in cryptorehidism and hypospadias[J].J Urol,2002,168(5):2170-2172.
  • 7NELSON CP,PARK JM,WAN J,et al.The increasing incidence of congenital penile anomalies in the United States[J].J Urol'2005,174(4 Pt 2):1573-1576.
  • 8SILVER RI,RUSSELL DW.5alpha-reduetsse type 2 mutations are present in Borne boys with isolated hypospadias[J].J Urol,1999,162(3 Pt 2):1142-1145.
  • 9MAKRIDAKIS NM,DI SALLERE,REICHARDT JK.Biochemical and phannaeogenetic dissection of human steroid 5 alpha-reduelaae type Ⅱ[J].Pharmacogenefies,2000,10(5):407-413.
  • 10THAI HT,KALBASI M,LAGERSTEDT K.et al.The Valine allele of the V89L polymorphism in the five-alpha reductase gene confers a reduced risk for hypospadias[J].J Clin Endocfinol Metab,2005.20(9):1-20.

二级参考文献2

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部